BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22047160)

  • 1. Translational research to develop a human PBPK models tool kit-volatile organic compounds (VOCs).
    Mumtaz MM; Ray M; Crowell SR; Keys D; Fisher J; Ruiz P
    J Toxicol Environ Health A; 2012; 75(1):6-24. PubMed ID: 22047160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a human Physiologically Based Pharmacokinetic (PBPK) Toolkit for environmental pollutants.
    Ruiz P; Ray M; Fisher J; Mumtaz M
    Int J Mol Sci; 2011; 12(11):7469-80. PubMed ID: 22174611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions.
    Aylward LL; Kirman CR; Blount BC; Hays SM
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):33-44. PubMed ID: 20685286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologically based pharmacokinetic (PBPK) tool kit for environmental pollutants--metals.
    Ruiz P; Fowler BA; Osterloh JD; Fisher J; Mumtaz M
    SAR QSAR Environ Res; 2010 Oct; 21(7-8):603-18. PubMed ID: 21120752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene.
    Liao KH; Tan YM; Clewell HJ
    Risk Anal; 2007 Oct; 27(5):1223-36. PubMed ID: 18076492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational estimation of errors generated by lumping of physiologically-based pharmacokinetic (PBPK) interaction models of inhaled complex chemical mixtures.
    LeFew W; El-Masri H
    Inhal Toxicol; 2012 Jan; 24(1):36-46. PubMed ID: 22149415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSARs for PBPK modelling of environmental contaminants.
    Peyret T; Krishnan K
    SAR QSAR Environ Res; 2011 Mar; 22(1-2):129-69. PubMed ID: 21391145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrahepatic metabolism by CYP2E1 in PBPK modeling of lipophilic volatile organic chemicals: impacts on metabolic parameter estimation and prediction of dose metrics.
    Yoon M; Madden MC; Barton HA
    J Toxicol Environ Health A; 2007 Sep; 70(18):1527-41. PubMed ID: 17710613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Model Template Approach for Rapid Evaluation and Application of Physiologically Based Pharmacokinetic Models: Extension to Volatile Organic Compounds.
    Bernstein AS; Prasad B; Schlosser PM; Kapraun DF
    Toxicol Sci; 2023 Mar; ():. PubMed ID: 36869685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A distributed parameter physiologically-based pharmacokinetic model for dermal and inhalation exposure to volatile organic compounds.
    Roy A; Weisel CP; Lioy PJ; Georgopoulos PG
    Risk Anal; 1996 Apr; 16(2):147-60. PubMed ID: 8638037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of three physiologically based pharmacokinetic (PBPK) modeling tools for emergency risk assessment after acute dichloromethane exposure.
    Boerleider RZ; Olie JD; van Eijkeren JC; Bos PM; Hof BG; de Vries I; Bessems JG; Meulenbelt J; Hunault CC
    Toxicol Lett; 2015 Jan; 232(1):21-7. PubMed ID: 25455448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring Mechanistic Toxicity of Mixtures Using PBPK Modeling and Computational Systems Biology.
    Ruiz P; Emond C; McLanahan ED; Joshi-Barr S; Mumtaz M
    Toxicol Sci; 2020 Mar; 174(1):38-50. PubMed ID: 31851354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of the impact of multi-route co-exposures on human variability in toxicokinetics: A case study with binary and quaternary mixtures of volatile drinking water contaminants.
    Tohon H; Valcke M; Haddad S
    J Appl Toxicol; 2019 Jul; 39(7):974-991. PubMed ID: 30834571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
    Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
    Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of human exposure modeling activities at the USEPA's National Exposure Research Laboratory.
    Furtaw EJ
    Toxicol Ind Health; 2001 Jun; 17(5-10):302-14. PubMed ID: 12539877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated QSAR-PBPK modelling approach for predicting the inhalation toxicokinetics of mixtures of volatile organic chemicals in the rat.
    Price K; Krishnan K
    SAR QSAR Environ Res; 2011 Mar; 22(1-2):107-28. PubMed ID: 21391144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and modeling of the impact of coexposures to VOC mixtures on urinary biomarkers.
    Marchand A; Aranda-Rodriguez R; Tardif R; Nong A; Haddad S
    Inhal Toxicol; 2016; 28(6):260-73. PubMed ID: 27053005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing interaction thresholds for trichloroethylene in combination with tetrachloroethylene and 1,1,1-trichloroethane using gas uptake studies and PBPK modeling.
    Dobrev ID; Andersen ME; Yang RS
    Arch Toxicol; 2001 May; 75(3):134-44. PubMed ID: 11409535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomonitoring Equivalents for benzene.
    Hays SM; Pyatt DW; Kirman CR; Aylward LL
    Regul Toxicol Pharmacol; 2012 Feb; 62(1):62-73. PubMed ID: 22178585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demographic, residential, and behavioral determinants of elevated exposures to benzene, toluene, ethylbenzene, and xylenes among the U.S. population: results from 1999-2000 NHANES.
    Symanski E; Stock TH; Tee PG; Chan W
    J Toxicol Environ Health A; 2009; 72(14):915-24. PubMed ID: 19557620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.